See http://www.strategicdc.com/18102 for more details or contact us at info@strategicdc.com
We are looking to find an energetic, enthusiastic FT Associate to join our team. We have 3 clinics located in the beautiful La Crosse, WI area. We are looking for someone with a passion for chiropractic and someone who cares for the individual patient. While we treat a wide variety of musculoskeletal injuries, we focus on patient centered care. We look forward to hearing from you.
Treating bleeding gums naturally is much simpler than it looks and It has no side effects on your health. This = Winner :)
Link to The Healthy mouth blend full review:
https://bestoralbelectrictoothbrush.com/natural-remedy-for-gum-disease-all-organic-and-no-side-effects/
The Häagen-Dazs brand is helping to change the way ingredients are grown to better support bee populations by working hand-in-hand with its farmer suppliers. The internationally-recognized ice cream brand has installed one of the largest, privately funded pollinator habitats on the farmland of its almond supplier in California’s Central Valley. No stranger to helping the bees, the brand aims to impact additional ingredients used throughout its super-premium ice cream portfolio and positively influence sustainable agriculture practices.
The “Häagen-Dazs Loves Honey Bees” program launched in 2008, and today is expanding from research and educational funding to hands-on initiatives that will rejuvenate pollinator habitats to allow native bees to flourish. Located in Chowchilla, California, the habitat consists of six and a half miles of hedgerow and 11,000 native drought-tolerant shrubs and flowering plants, impacting 840 acres of farmland. In order to supply what pollinators need, the Häagen-Dazs brand worked with expert agronomists and the Xerces Society to maximize the impact of the habitat by choosing regional plants that are attractive to pollinators. Looking forward, the team will work to create custom habitats for more of its ingredient suppliers who depend on bees to pollinate their crops.
To view the multimedia release go to:
https://www.multivu.com/players/English/8075051-haagen-dazs-sustainable-agriculture-bees-pollinator-habitats/
Cold brew coffee lovers can now make their favorite cold brew beverages at home with ease thanks to the new KitchenAid® Cold Brew Coffee Maker. Making its debut today at the International Housewares Show, the new addition to the brand’s popular craft coffee collection brings the high quality taste and experience of coffee shop cold brew into the home.
“Cold brew coffee is an increasingly popular brewing technique known for producing a smooth, rich and full bodied flavor,” said Dan Rellis, Senior Manager of the KitchenAid® Coffee Category. “We’re thrilled to offer coffee enthusiasts a new way to treat themselves to their favorite cold brew coffee beverage in the comfort of their own home.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8013852-kitchenaid-cold-brew-coffee-maker/
Ben & Jerry’s is giving everyone a taste of the days of carefree (and responsibility-free) Saturday mornings with a new lineup of ice cream flavors inspired by cereal, available in Scoop Shops starting on March 7, National Cereal Day. The three new Cereal Splashbacks bring the awesomely unmistakable taste of some favorite milk-splashed morning cereals, just frozen. The new flavors pay a nostalgic tribute to childhood cereal favorites, and the Cereal Splashbacks are available only at Ben & Jerry’s Scoop Shops.
To view the multimedia release go to:
https://www.multivu.com/players/English/8026454-ben-and-jerrys-cereal-splashback-flavors/
Dickey’s Barbecue Pit is offering its signature holiday meats and feasts this year, but with an exciting new meat available to spice up the holiday table. This year for the first time, Dickey’s will offer Prime Rib as a holiday meat choice. The Prime Rib, like Dickey’s signature turkey and ham, is pre-smoked and seasoned with Dickey’s own special spice blend – an easy and unexpected holiday treat to wow your guests.
Guests can order online until a day before Thanksgiving or other holiday gatherings, or call the nearest Dickey’s location to place the order. Find the Dickey’s nearest you here.
To view the multimedia release go to:
http://www.multivu.com/players/English/7717953-dickeys-barbecue-holiday-feasts-prime-rib/
Abbott announced today that the U.S. Food and Drug Administration has approved the company’s Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people with coronary artery disease in the United States.
Absorb is the only fully dissolving stent approved for the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide, despite decades of therapeutic advances. While stents are traditionally made of metal, Abbott’s Absorb stent is made of a naturally dissolving material, similar to dissolving sutures. Absorb disappears completely in approximately three years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants that restrict vessel motion for the life of the person treated.
To view the multimedia release go to:
http://www.multivu.com/players/English/7826651-abbott-fda-approval-stent/
Spotted: Nick Offerman and his dad Ric fishing in a handmade canoe on a serene and quiet lake, communicating as only fathers and sons do.
Of the experience, Offerman said, “Working with my Dad (aka my hero) was a sincere honor and a treat - especially since all we had to do was go fishing. And if people have enjoyed my stoic expressions, then I expect they’re about to have their hats fly off when they lay eyes on the face of the august edifice from whence I sprung.”
Grab your dad, pour yourselves a glass of Lagavulin and enjoy responsibly.
To view the multimedia release go to:
http://www.multivu.com/players/English/7848951-my-tales-of-whisky-fathers-day/
The St. Baldrick’s Foundation, a volunteer-powered charity dedicated to funding childhood cancer research, announces its Kids Are Special: Let’s Treat Them That Way national campaign. Focused on celebrating kids and giving them the happy childhoods they deserve, the campaign highlights the need for finding treatments that are specifically designed for kids with cancer.
With this bold new initiative, St. Baldrick’s looks to change the narrative around pediatric cancers, by showing kids as their truest selves – fun-loving, carefree, refreshingly honest, and always a little goofy. St. Baldrick’s puts the emphasis back on kids, while disempowering the label of “cancer.” All communication is strategically designed to remind us all that as adults we have the power to give kids happy childhoods free from cancer by helping to fund the best research worldwide. The campaign includes TV, print, radio, digital, and billboard placements featuring real kids doing kid-like things; from playing with their food to getting caught with paint on their faces, all with the message: Kids Are Special: Let’s Treat Them That Way.
To view the multimedia release go to:
http://www.multivu.com/players/English/7610752-st-baldricks-kids-are-special/
Well, this certainly break's my 1 song per month rule. I can't help it. Halloween's got me by the Candy Apples. Normally, I create the music first and then I make a video for it later but I didn't want to go through my video madness routine at the very end and so I did a little bit of this and a little bit of that and got it all wrapped up together at the same time. I didn't have the opportunity to take the song out for a test drive as I always take a cruise with my bro and we listen to it in his car and then later I make some adjustments at home. It sound's fine to me through my laptop and the video look's okay and so I'm just gonna upload it as is.
Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, announced today the launch of its Hidden ScarTM Surgery program designed to certify surgeons and establish Centers of Excellence at major cancer centers and hospitals across the country. This innovative program will train surgeons on advanced minimally invasive and minimal access surgical approaches that deliver optimal clinical and aesthetic outcomes for patients. As part of the company’s broader women’s health initiative, Invuity is hosting a Hidden Scar Breast Cancer Surgery training course in advance of the American College of Surgeons (ACS) Clinical Congress.
Invuity aims to transform the surgical treatment of breast cancer with this advanced surgical approach for nipple sparing mastectomies and lumpectomies (breast conserving surgery). Hidden Scar Breast Cancer Surgery expands surgical options for patients, offering superior cosmetic outcomes that can improve their psychological and emotional recovery and enhance quality of life after surgery.1
With growing demand for less invasive alternatives to breast cancer surgery, surgeons need to operate through smaller incisions with limited fields of vision. Invuity’s illumination technology allows surgeons to access and visualize the entire breast cavity through discrete incision locations, enabling surgeons to safely and effectively treat breast cancer while preserving the natural shape of the breast and thereby minimizing and hiding the scars.
To view the multimedia release go to:
http://www.multivu.com/players/English/7644051-invuity-hidden-scar-breast-cancer-surgery-program/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
